The role of hepatitis C virus NS5A region mutation and SNP IL-28B of host to support successful pegylated interferon and ribavirin treatment in patients with HCV-HIV coinfection: a prospective cohort study

Hubungan SNP IL-28B Pejamu dengan Respons Virologis Menetap serta Kaitannya dengan Ekspresi Interferon-3 dan Reseptor Interferon-λ3 di Jaringan Hati pada Pasien Hepatitis C Kronik dengan Pengobatan Pegylated Interferon Α2 dan Ribavirin = Association between SNP IL-28B and Sustained Virological Response and Its Relation with Expression of Interferon Lambda-3 and Interferon Lambda-3 Receptor in Liver Tissues of Chronic Hepatitis C Patients Treated with Pegylated Interferon α2 and Ribavirin

Hubungan SNP IL-28B Pejamu dengan Respons Virologis Menetap serta Kaitannya dengan Ekspresi Interferon-3 dan Reseptor Interferon-λ3 di Jaringan Hati pada Pasien Hepatitis C Kronik dengan Pengobatan Pegylated Interferon Α2 dan Ribavirin = Association between SNP IL-28B and Sustained Virological Response and Its Relation with Expression of Interferon Lambda-3 and Interferon Lambda-3 Receptor in Liver Tissues of Chronic Hepatitis C Patients Treated with Pegylated Interferon α2 and Ribavirin

Prevalensi dan sebaran faktor risiko anemia pada pasien hepatitis C kronik yang menjalani terapi kombinasi interferon alfa dan ribavirin = Prevalence anaemia and risk factor distribution in patients with chronic hepatitis C who received interferon alfa and ribavirin combination therapy

Combination of interferon alfa-2b and ribavirin in relapsed or non-responding chronic hepatitis C patients following interferon therapy